Cargando…

Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules

BACKGROUND: Inactivated polio vaccine (IPV) is now the only source of routine type 2 protection. The relationship, if any, between vaccine-induced type 2 humoral and intestinal immunity is poorly understood. METHODS: Two clinical trials in five Latin American countries of mixed or sequential bOPV-IP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandyopadhyay, Ananda S., Asturias, Edwin J., O'Ryan, Miguel, Oberste, M. Steven, Weldon, William, Clemens, Ralf, Rüttimann, Ricardo, Modlin, John F., Gast, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725506/ https://www.ncbi.nlm.nih.gov/pubmed/29150209 http://dx.doi.org/10.1016/j.vaccine.2017.11.006

Ejemplares similares

Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination
por: Yu-ping, Zhao, et al.
Publicado: (2023)

Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas
por: Pedreira, Cristina, et al.
Publicado: (2017)

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame
por: Gaensbauer, James T, et al.
Publicado: (2018)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016
por: Farrell, Margaret, et al.
Publicado: (2017)

Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America
por: Lopez-Medina, Eduardo, et al.
Publicado: (2017)

The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016
por: Bassey, Bassey Enya, et al.
Publicado: (2018)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
por: Martini Rodrigues, Camila Cristina, et al.
Publicado: (2022)

Mobilizing political support proved critical to a successful switch from tOPV to bOPV in Kano, Nigeria 2016
por: Abba, Bashir, et al.
Publicado: (2018)

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy
por: Chen, Shiyi, et al.
Publicado: (2022)

Studies on immune responses and interference of oral polio vaccine (OPV) on seroconversion to rotavirus vaccine
por: Migasena, S., et al.
Publicado: (1992)

Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand
por: Sanchez, Leilani, et al.
Publicado: (2023)

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience()
por: Macklin, Grace R., et al.
Publicado: (2023)

Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial
por: Kanungo, Suman, et al.
Publicado: (2017)

Safeguarding vaccine production and supply strategies for polio eradication endgame
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2021)

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants
por: Wright, Peter F, et al.
Publicado: (2016)

Preventing Polio Post-eradication: Revertant Proportion Patterns of OPV Serotypes
por: Altamirano, Jonathan, et al.
Publicado: (2017)

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
por: Wahid, Rahnuma, et al.
Publicado: (2021)

Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV
por: Aaby, Peter, et al.
Publicado: (2022)

Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
por: Costa, Galileu Barbosa, et al.
Publicado: (2016)

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation
por: Kalkowska, Dominika A, et al.
Publicado: (2023)

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15–18 months
por: Sáez-Llorens, Xavier, et al.
Publicado: (2020)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Triumphs of Immunization
por: Modlin, John F, et al.
Publicado: (2021)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication
por: Modlin, John F, et al.
Publicado: (2021)

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age
por: Bravo, Lulu C., et al.
Publicado: (2020)

Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial
por: Rivera, Luis, et al.
Publicado: (2017)

Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo
por: Voorman, Arend, et al.
Publicado: (2017)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China
por: Xu, Yuyang, et al.
Publicado: (2022)

Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

Assessment of immunity to polio among Rohingya children in Cox’s Bazar, Bangladesh, 2018: A cross-sectional survey
por: Estivariz, Concepcion F., et al.
Publicado: (2020)

Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system
por: White, Jessica A, et al.
Publicado: (2014)

Measuring polio immunity to plan immunization activities
por: Voorman, Arend, et al.
Publicado: (2016)

Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama
por: Rojas-Bonilla, Magda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8ekekbiu0a3heibsqi8tout63